
Nausea Medicine Market
Description
Nausea Medicine Market, By Drug Class (Antihistamines, Anticholinergics, Serotonin Antagonists, Dopamine Antagonists, Cannabinoids, Others), By Route of Administration( Oral, Injectable, Transdermal, Rectal, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Geography (North America, Europe,Asia Pacific, Latin America, Middle East and Africa), And By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Nausea, an unsettling sensation often accompanied by the urge to vomit, can significantly disrupt one’s daily life. Nausea medicine, a vital aspect of modern healthcare, aims to alter to alleviate this distressing symptom and improve overall well-being. Designed to target body’s specific receptors responsible for nausea and vomiting, these medications come in various forms, including pills, liquids and patches. By effectively blocking these receptors, nausea medicine provides much needed relief to patients suffering from motion sickness, chemotherapy-included nausea, pregnancy-related discomfort and other related conditions. This introduction delves into the importance of these medicines in enhancing quality of life for individuals plagued by nauseous episodes.
Market Dynamics:
Increasing prevalence of nausea, advancements in drug formulations and increasing geriatric population is anticipated to drive growth of the global Nausea Medicine market over the forecast period. Moreover, growing awareness and diagnosis is also expected to boost the growth of the global Nausea Medicine market over the forecast period. Development of targeted therapies, expansion into emerging markets, combination therapies and non-pharmacological interventions are expected to create growth opportunities for the global Nausea Medicine market during the forecast period.
However, adverse effects and safety concerns, high cost of nausea medicines, lack of targeted therapies for specific causes and limited efficiency in some cases are expected to hamper growth of the Nausea Medicine market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the Nausea Medicine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Nausea Medicine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Johnson & Johnson, Bayer AG, Takeda Pharmaceutical Company Limited, AstraZeneca plc, Eli Lilly and Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The Nausea Medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Nausea Medicine market
- Global Nausea Medicine Market Segmentation, By Drug Class:
- Antihistamines
- Anticholinergics
- Serotonin Antagonists
- Dopamine Antagonists
- Cannabinoids
- Others
- Global Nausea Medicine Market Segmentation, By Route of Administration:
- Oral
- Injectable
- Transdermal
- Rectal
- Others
- Global Nausea Medicine Market Segmentation, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
- Global Nausea Medicine Market Segmentation, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profile:
- GlaxoSmithKline plc
- Pfizer Inc.
- Novartis International AG
- Sanofi S.A.
- Merck & Co., Inc.
- Johnson & Johnson
- Bayer AG
- Takeda Pharmaceutical Company Limited
- AstraZeneca plc
- Eli Lilly and Company
Table of Contents
150 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing prevalence of nausea
- Restraints
- Adverse effects and safety concerns
- Opportunities
- Development of targeted therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Nausea Medicine Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Nausea Medicine Market , By Drug Class, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Anticholinergics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Serotonin Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Dopamine Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cannabinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Other
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 6. Global Nausea Medicine Market , By Route of Administration, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 7. Global Nausea Medicine Market, By Distribution Channel, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 8. Global Nausea Medicine Market , By Geography, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 –2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- 9. Competitive Landscape
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck &Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eli Lily and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
- 10. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Nausea Medicine Market” - Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.